OrthoPediatrics Corp.
Stock Forecast, Prediction & Price Target

OrthoPediatrics Corp. Financial Estimates

OrthoPediatrics Corp. Revenue Estimates

OrthoPediatrics Corp. EBITDA Estimates

OrthoPediatrics Corp. Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$98.04M
 
N/A
$122.28M
 
24.72%
$148.73M
 
21.62%
Avg: $238.74M
Low: $234.29M
High: $243.81M
avg. 60.52%
Avg: $283.40M
Low: $279.59M
High: $287.68M
avg. 18.70%
Net Income
 
% change YoY
$-16.26M
 
N/A
$1.25M
 
107.73%
$-20.97M
 
-1767.24%
Avg: $-26.26M
Low: $-36.96M
High: $-6.34M
avg. -25.24%
Avg: $-19.43M
Low: $-38.77M
High: $12.01M
avg. 26.01%
EBITDA
 
% change YoY
$-6.11M
 
N/A
$-10.48M
 
-71.60%
$-8.38M
 
20.08%
Avg: $-21.02M
Low: $-21.47M
High: $-20.63M
avg. -150.87%
Avg: $-24.95M
Low: $-25.33M
High: $-24.62M
avg. -18.70%
EPS
 
% change YoY
-$0.84
 
N/A
$0.06
 
107.09%
-$0.92
 
-1643.62%
Avg: -$1.13
Low: -$1.63
High: -$0.28
avg. -22.64%
Avg: -$0.84
Low: -$1.71
High: $0.53
avg. 25.55%
Operating Expenses
 
% change YoY
$91.27M
 
N/A
$112.45M
 
23.19%
$137.01M
 
21.84%
Avg: $202.94M
Low: $199.16M
High: $207.25M
avg. 48.11%
Avg: $240.90M
Low: $237.66M
High: $244.53M
avg. 18.70%

FAQ

What is OrthoPediatrics Corp. stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 0.38% in 2025-2026.

We have gathered data from 5 analysts. Their low estimate is -36.96M, average is -26.26M and high is -6.34M.

What is OrthoPediatrics Corp. stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 39.61% in 2025-2026.

We have gathered data from 5 analysts. Their low revenue estimate is $234.29M, average is $238.74M and high is $243.81M.

What is OrthoPediatrics Corp. stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 1.45% in 2025-2026.

We have gathered data from 5 analysts. Their low earnings per share estimate is -$1.63, average is -$1.13 and high is $-0.28.

What is the best performing analyst?

In the last twelve months analysts have been covering OrthoPediatrics Corp. stock. The most successful analyst is Richard Newitter.